| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.PHRS.2014.08.001 |
| P698 | PubMed publication ID | 25151891 |
| P50 | author | Shun-Wan Chan | Q42741197 |
| P2093 | author name string | Philip Chiu-Tsun Tang | |
| Yam-Fung Ng | |||
| Michael Gyda | |||
| Susan Ho | |||
| P2860 | cites work | Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor | Q36086859 |
| P921 | main subject | hopelessness | Q30317309 |
| P304 | page(s) | 88-115 | |
| P577 | publication date | 2014-08-22 | |
| P1433 | published in | Pharmacological Research | Q15724622 |
| P1476 | title | Resveratrol and cardiovascular health--promising therapeutic or hopeless illusion? | |
| P478 | volume | 90 |
| Q38365582 | 3,4',5-trans-Trimethoxystilbene; a natural analogue of resveratrol with enhanced anticancer potency |
| Q35894953 | A Systematic Review of the Efficacy of Bioactive Compounds in Cardiovascular Disease: Phenolic Compounds |
| Q39402253 | Antioxidants Mediate Both Iron Homeostasis and Oxidative Stress |
| Q39004398 | Bioactive compounds as an alternative for drug co-therapy: Overcoming challenges in cardiovascular disease prevention |
| Q26776446 | Caloric restriction and exercise "mimetics'': Ready for prime time? |
| Q36525791 | Chronic resveratrol reverses a mild angiotensin II-induced pressor effect in a rat model |
| Q53207353 | Creating a Water-Soluble Resveratrol-Based Antioxidant by Site-Selective Enzymatic Glucosylation. |
| Q35333467 | Dose response biology of resveratrol in obesity |
| Q38835403 | During yeast chronological aging resveratrol supplementation results in a short-lived phenotype Sir2-dependent |
| Q48141180 | Effect of resveratrol on experimental non-alcoholic fatty liver disease depends on severity of pathology and timing of treatment. |
| Q39403124 | Efficacy and Mechanisms of Chinese Medicine on the Modulation of Myocardial Autophagy in Cardiovascular Disease |
| Q28066377 | Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy |
| Q91972699 | Higenamine exerts an antispasmodic effect on cold-induced vasoconstriction by regulating the PI3K/Akt, ROS/α2C-AR and PTK9 pathways independently of the AMPK/eNOS/NO axis |
| Q46500197 | Hydrogen sulfide: A novel mechanism for the vascular protection by resveratrol under oxidative stress in mouse aorta. |
| Q91793998 | No beneficial effects of resveratrol supplementation on atherogenic risk factors in patients with nonalcoholic fatty liver disease |
| Q40122113 | Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease |
| Q64086246 | Promoting healthspan and lifespan with caloric restriction in primates |
| Q92702687 | Recent Advances in Pharmacological and Non-Pharmacological Strategies of Cardioprotection |
| Q26752801 | Resveratrol and Cardiovascular Diseases |
| Q64112604 | Resveratrol and Its Effects on the Vascular System |
| Q26772210 | Resveratrol and Omega-3 Fatty Acid: Its Implications in Cardiovascular Diseases |
| Q46772238 | SIRT1 Regulates Cognitive Performance and Ability of Learning and Memory in Diabetic and Nondiabetic Models |
| Q38551719 | Selected Micronutrients in Cognitive Decline Prevention and Therapy. |
| Q35768345 | Sirtuins, aging, and cardiovascular risks |
Search more.